Medication info
Telmisartan 40 mg Tablet

Telmisartan 40 mg Tablet

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tablet
Manufacturer / importer
Unimed Pharmaceuticals Co., Ltd.
Appearance
White oblong tablet
Packaging
30 tablets (10 tablets/Alu-Alu×3)
Approval status
Active

MFDS item code 201804271 · Approved 2018.10.29 · Insurance code 649507790

Summary

Main use
Treatment of essential hypertension and prevention of cardiovascular diseases (including myocardial infarction and stroke)
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan should be administered orally with water at a dose of 40 mg once daily, and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This drug has an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this drug be administered orally with water at a dose of 80 mg once daily, and it may be taken with or without food. The effect of reducing the risk of cardiovascular morbidity and mortality at doses below 80 mg is unknown. When starting treatment with this drug to reduce cardiovascular risk, it is recommended that blood pressure be monitored, and appropriate adjustment of antihypertensive medication may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Unimed Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and prevention of cardiovascular diseases (including myocardial infarction and stroke)

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attack
  • high-risk diabetes with clinical evidence of end-organ damage
View approved original text

This medication helps to control blood pressure in patients with essential hypertension, promoting overall health. It is also effective in reducing the risk of heart attack, stroke, and mortality from cardiovascular diseases in patients over 55 who are at high risk of cardiovascular disease or who cannot use ACE inhibitors. It is particularly useful for high-risk diabetes patients with a history of coronary artery disease, peripheral artery disease, stroke, transient ischemic attacks, or evidence of end-organ damage. By lowering cardiovascular disease risk and stabilizing blood pressure, it improves the overall cardiovascular health of patients.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan should be administered orally with water at a dose of 40 mg once daily, and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This drug has an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this drug be administered orally with water at a dose of 80 mg once daily, and it may be taken with or without food. The effect of reducing the risk of cardiovascular morbidity and mortality at doses below 80 mg is unknown. When starting treatment with this drug to reduce cardiovascular risk, it is recommended that blood pressure be monitored, and appropriate adjustment of antihypertensive medication may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can cause serious harm and risk of death to the fetus and newborn during pregnancy; therefore, treatment should be discontinued immediately if pregnancy is confirmed. It should not be administered to pregnant women, women of childbearing potential, patients with severe liver disease, or patients with certain hereditary diseases. Elderly patients, patients with hyperkalemia, and patients with mild to moderate liver dysfunction should use this medication with caution as there is a risk of rapidly dropping blood pressure. Blood pressure, kidney function, and serum potassium levels should be monitored regularly during treatment to ensure no abnormality. Serious side effects such as angioedema, liver dysfunction, renal failure, shock, and syncope may occur, and the physician should be consulted immediately if symptoms arise. Caution is needed when taken with other antihypertensive medications, as the blood pressure-lowering effect may be increased. The risk of hyperkalemia and worsening kidney function is particularly high when used in combination with other RAAS agents or potassium-sparing diuretics. It is advisable to discontinue this medication 24 hours before surgery, and caution should be exercised during activities such as driving or operating machinery due to the possibility of dizziness or fainting. Safety and effectiveness in pediatric patients have not been established, thus it is not recommended. Overdose may result in hypotension, dizziness, and acute renal failure; immediate medical attention should be sought in such cases. Store in a place out of reach of children and avoid moisture; it is best to open the package just before taking the dose.

Side effects

  • Upper respiratory infections
  • pharyngitis
  • sinusitis
  • urinary tract infections
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 121 more
  • anaphylactic reactions
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbances
  • liver function abnormalities
  • liver disorders
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • low back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased uric acid
  • elevated liver enzymes
  • increased creatine kinase in the blood
  • decreased hemoglobin
  • hypoglycemia
  • fatigue
  • hunger
  • cold sweat
  • tremors
  • decreased concentration
  • convulsions
  • altered consciousness
  • facial swelling
  • lip swelling
  • pharyngeal and laryngeal swelling
  • lingual swelling
  • angioedema
  • severe hyperkalemia
  • renal failure
  • shock
  • syncope due to hypotension
  • loss of consciousness
  • liver dysfunction
  • jaundice
  • dyspnea
  • hypotension
  • laryngeal edema
  • interstitial pneumonia
  • fever
  • cough
  • abnormal chest X-ray
  • rhabdomyolysis
  • myalgia
  • weakness
  • elevated myoglobin in blood and urine
  • palpitations
  • fatigue
  • nausea
  • inadequate effect
  • headache
  • dizziness
  • cough
  • dyspepsia
  • arrhythmia
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • loss of appetite
  • facial swelling
  • rash
  • alopecia
  • conjunctivitis
  • ringing in the ears
  • petechiae
  • headache
  • dizziness
  • myalgia
  • dermatitis
  • dizziness
  • dyspepsia
  • cough
  • abdominal pain
  • loss of appetite
  • weakness
  • mesenteric edema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. Storage temperature should be maintained between 1°C and 30°C to preserve the drug's effectiveness and safety.

Appearance and packaging

Appearance

White oblong tablet

Package unit

30 tablets (10 tablets/Alu-Alu×3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.